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Abstract 
 
The anticonvulsant activity of the aqueous extract of Convolvulus pluricaulis Chois 
(Shankhapuspi) was studied against Strychnine induced convulsions. 
Seizure was induced by Strychnine in Shankhapuspi used animal model. The co-
administration of the standard anticonvulsant drug Phenytoin sodium and aqueous extract of 
Shankhapuspi resulted in significant anticonvulsant activity when compared to the 
anticonvulsive activity of Phenytoin sodium. 
The results of the study clearly suggested that Shankhapuspi can be prescribed as a 
co-therapeutic agent of Phenytoin for arresting seizures induced by Strychnine. 
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Introduction: 
Convulsive disorders are seen in 
0.4 to 2 percent population in the world 
and that can occur at any age. (1) Recently 
it is one of the important subjects of 
concern especially for children and 
pregnant women. Being a global problem, 
the evaluation of patent and safe 
anticonvulsants is a matter of concern. The 
more recent studies show that the 
anticonvulsants used are hydantoins, 
valporate, barbiturates and 
benzodiazepines.(2) However due to their 
adverse effects like dependence, addiction, 
withdrawal symptoms and longer duration 
of treatment, the Ayurvedic products are 
preferred now a days. Shankhapuspi 
(Convulvulus pluricaulis Chois) belongs to 
Convolvulaceae family and has been 
mentioned in Ayurveda, as a Rasayana 
which is mainly advocated for use on 
rejuvenation therapy. It is said to be the 
best among the medhya rasayana 
(intellectual promoting drug) (3) and is 
frequently indicated for the treatment of 
various mental diseases like epilepsy, 
insanity, obsession etc. Anticonvulsive, 
hypnotic, anxiolytic and mild analgesic 
actions of C. pluricaulis have been studied 
(4) and found that, extract of C. pluricaulis 
antagonizing the electrically induced 
convulsive seizures in rats and tremorine 
induced tremors in mice. Further 
antioxidant and anticonvulsant activity of 
methanolic extract of  C.pluricaulis has 
shown to reduce the mean recovery time in 
maximal electricshock seizure 
model.(5,6)Though various evaluation of 
anticonvulsive activity works were done 
with Convolvulus pluricaulis(7,8,9,10), 
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but use of its aqueous extract on strychnine 
induced seizure is done for the first time in 
the present work. 
 
Materials and Method: 
The study was carried out in the 
Department of Dravyaguna, Institute of 
Post Graduate Ayurvedic Education and 
Research, Kolkata and in the Department 
of Chemical Technology, University of 
Kolkata.  
Object: 
The main aim of the study was to evaluate 
the anticonvulsant activity of 
Shankhapuspi (Convolvulus pluricaulis 
Chois) on Strychnine induced convulsive 
seizures in animal models. This assay was 
used to evaluate the anticonvulsant activity 
of Sankhapuspi in convulsion, spasm of 
Tetanus etc. The interval of occurrence of 
tonic extensor convulsions and death 
following strychnine injection was noted. 
(11) 
 
Collection of Chemical and Material: 
The analytical grade of Strychnine 
Hydrochloride (S) and Phenytoin sodium 
(Epsolin) (12) was used for the present 
study were locally purchased. 
 
Collection of Plant Material: 
Whole part of the plant of 
Convolvulus pluricaulis was purchased 
from the local supplier and was 
authenticated by the institute as per usual 
norms.  
 
Preparation of Aqueous Extract: 
The fine powder of the herb 
Shankhapuspi was taken in a round bottle. 
Distilled water was added and extraction 
procedure was performed by decoction 
method for 48 hrs. After complete 
extraction, filtration method was adopted 
for getting clear extract solution. Filtrate 
clear extract solution was dried under 
rotary vacuum driers for complete removal 
of moisture and was placed in steam bath 
for few minutes. 
Dose Selection: 
Five random doses were selected 
for 6 separate groups of animals. The 
lowest dose was 100 mg/kg bw and the 
highest dose was 500 mg/kg bw. Drugs 
were measured accordingly and dissolved 
in distilled water. A stock was prepared 
and amount required for each rat was 
calculated. 
 
Selection of Standard Drug: 
Phenytoin sodium (epsolin) was 
choosen as standard drug for inhibiting 
seizures in the dose of 135 mg/kg bw, 
intraperitoneally. (13) 
 
Collection of Animals: 
Albino mice of either sex were 
collected and their weight varied between 
20 gm to 25 gm. They were maintained on 
standard laboratory diet and provided free 
access to water. 
Grouping of Animals: 
All the animals (mice) were 
divided into 9 groups each containing 5 in 
number. The groups of animal were kept 
in their respective cages marked on them. 
The 9 cages were marked with the sign. C, 
C100, C200, C300, C400, C500, Strychnine, 
Phenytoin and Phenytoin + C400 to indicate 
control (normal saline), aqueous extract of 
Shankhapuspi in 100 mg, 200 mg, 300 mg, 
400 mg and 500 mg/kg bw, respectively. S 
indicates Strychnine Hcl (S) administrated 
in the dose of 2 mg/kg bw, 
intraperitoneally. (14) 
 
Number of Experiments: 
5 sets of experiment were 
performed for evaluating anticonvulsant 
property of Convolvulus pluricaulis and 
the result obtained from the experiment 
were verified by various statistical 
analyses. 
 
Procedure of Drug Administration: 
The aqueous extract of 
Convolvulus pluricaulis was administered 
orally using feeding cannula of 2.5 cm 
Published online in http://ijam.co.in 
ISSN:  0976-5921 
International Journal of Ayurvedic Medicine, 2012, 3(2), 82-87 
 
84 
long made up of Silver (AG) metal. It was 
introduced safely direct into the stomach. 
In this way the drug was administrated in 
accurate dose without useless mechanical 
loss. During administration, mice were 
carefully handled by which traumatic 
injury was avoided. Aqueous extract of 
Convolvulus pluricaulis was administered 
daily for14 consecutive days. 
 
Experimental Procedure Strychnine Hcl 
(S) induced convulsion: 
Aqueous extract of C. pluricaulis 
was administrated to the experimental 
animal for 14 days prior to induction of 
convulsion in mice. Before 12 hours of 
induction of convulsion the food was 
withdrawn. In the morning the last dose of 
trial drug was administrated orally 1 hr 
prior to induce convulsion with strychnine. 
Each mouse was placed in to an individual 
plastic cage for observation for 1 hr. The 
delay of onset was calculated in 
comparison with the control and standard 
groups. 
 
Observation: 
 ED50 value was calculated. Further 
more, the time interval between Strychnine 
Hcl (S) injection and occurrence of seizure 
was measured. The delay onset was 
calculated in comparison with the control 
and standard groups. 
Statistical Analysis: 
 The percentage changes due to 
effect of C. pluricaulis and Phenytoin 
sodium were calculated with respect to 
control. Various statistical analysis such as 
student‘t’ test, analysis of variance 
(ANOVA) and various multiple 
comparison analysis were performed to 
verify the level of significance. 
 
Results and Discussion: 
 Different studies on Convolvulus 
pluricaulis were studied by the scholars 
from time to time. V.N. Sharma (1965) et 
al studied anti-convulsive effect of 
C.pluricaulis against electrically induced 
seizures, which showed the inhibitory 
effect of the drug. Present study showed 
significant anticonvulsant effect of the 
drug at the dosage of 400 mg/kg bw along 
with 135 mg/kg bw of Phenytoin sodium. 
 The results, verified by statistical 
analysis (t-test and confidence level), are 
shown in appropriate tables. The analysis 
of variance (ANOVA) in two ways 
between the samples and between the 
animal sets and rank means have been 
shown. 
The methods of evaluating 
anticonvulsive activity of Convolvulus 
pluricaulis in different doses along with 
Phenytoin are listed in Tab.  – 1. The 
relative percent changes with respect to 
control along with statistical data have 
been listed in Tab. – 1 and 2 & Fig. 1. 
 
 
Table-1: Effect of Convolvulus pluricaulis (C) on Strychnine (S) induced convulsion. 
 
Sampl
e 
A1 
 
A2 A3 
 
A4 
 
A5 
 
Average 
onset of 
convulsi
on 
(minute) 
± S.E. 
Relat
ive 
perc
ent 
chan
ge 
Average 
onset of 
convulsi
on 
(minute) 
± S.E. 
Relat
ive 
perc
ent 
chan
ge 
Average 
onset of 
convulsi
on 
(minute) 
± S.E. 
Relat
ive 
perc
ent 
chan
ge 
Average 
onset of 
convulsi
on 
(minute) 
± S.E. 
Relat
ive 
perc
ent 
chan
ge 
Average 
onset of 
convulsi
on 
(minute) 
± S.E. 
Relat
ive 
perc
ent 
chan
ge 
Contro
l 
58.8 ± 
0.80 
 
- 57.60±1.
666 
- 
 
57.6±1.6
66 
 
- 56.8±1.0
67 
 
- 
 
58.2±0.9
16 
- 
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C100 6.884±0.
22 
 
88.1
71
a
 
6.276±0.
331 
 
89.1
04a 
6.816±0.
34 
 
89.2
60
a
 
7.008±0.
36 
87.6
61
a
 
6.784±0.
377 
 
88.3
43
a
 
C200 7.848±0.
376 
 
86.5
15
a
 
 
7.156±0.
349 
87.5
76
a
 
 
8.04±0.3
51 
 
86.0
41
a
 
 
7.528±0.
358 
 
86.7
46
a
 
 
8.238±0.
302 
 
85.8
45
a
 
 
C300 9.896±0.
576 
 
82.9
96
a
 
 
9.056±0.
813 
 
84.2
77
a
 
9.12±0.3
57 
 
84.1
66
a
 
 
8.424±0.
38 
85.1
69
a
 
 
8.68±0.4
07 
 
85.0
85
a
 
C400 11.91±1.
069 
79.5
36
a
 
10.622±
0.901 
81.5
59
a
 
11.014±
0.764 
80.8
78
a
 
 
9.516±0.
93 
83.2
46
a
 
 
12.78±1.
655 
78.0
41
a
 
C500 13.12±0.
905 
77.4
57
a
 
13.692±
0.63 
76.2
29
a
 
12.28±0.
559 
78.6
80
a
 
 
10.344±
1.367 
 
81.7
88
a
 
 
13.306±
1.720 
77.1
37
a
 
Strych
nine 
(S) 
1.876±0.
152 
96.7
76
a
 
2.162±0.
30 
96.2
46
a
 
2.028±0.
295 
96.4
79
a
 
 
2.58±0.3
4 
 
95.4
57
a
 
 
2.148±0.
294 
96.3
09
a
 
Phenyt
oin 
50.984±
1.822 
12.3
98
a
 
49.796±
0.927 
1.54
8
a
 
47.758±
2.791 
17.0
86
b
 
 
47.616±
1.858 
16.1
69
b
 
49.426±
1.741 
15.0
75
b
 
Phenyt
oin + 
C400 
56.316±
1.395 
3.23
7
d
 
54.8±1.0
19 
4.86
1
d
 
50.102±
2.750 
13.0
17
b
 
 
53.146±
1.466 
6.43
3
c
 
54.012±
1.761 
7.19
5
c
 
 
A1-A5 indicate experimental sets 
≠ Average (minute) of five observations 
S.E. = Standard error (n = 5) 
C100, C200, C300, C400 and C500 indicate C.pluricaulis in the doses of 100 mg, 200mg, 300mg, 
400mg and 500mg per kg body wt. respectively. Control indicates administration of normal 
saline. Phenytoin administered as standard drug in the dose of 135 mg per kg I.P. 
 
Reproducibility values are measured by ‘t’ test and the values are significant at ap < 0.01; 
b
p>0.1. 
 
Table-2: Statistical analysis of variance (ANOVA) and multiple comparision analysis of 
C.pluricaulis of different doses on Strychnine (S) induced convulsion. 
 
ANOVA 
(Two ways) 
Multiple comparisons 
Least significant 
different 
procedure 
Student zed range 
procedure 
  Duncan’s new 
multiple range 
procedure 
                        
 F1=6411.189
a
 
(df=7,28) 
 
F2=1.383
b 
(df=4,28) 
 
 
Critical 
difference=1.4491 
 
(C100)(C200) 
(C300)(C400)(C500) 
(Phenytoin) 
(Phenytoin+C400) 
Critical 
difference=3.9195 
 
(C100)(C200) 
(C300)(C400)(C500) 
(Phenytoin) 
(Phenytoin+C400) 
Critical 
difference=3.0538 
 
(C100)(C200) 
(C300)(C400)(C500) 
(Phenytoin) 
(Phenytoin+C400) 
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C100, C200, C300, C400 and C500 indicate C.pluricaulis in the doses of 100 mg, 200mg, 
300mg, 400mg and 500mg per kg body wt. respectively. Phenytoin administered as standard 
drug in the dose of 135 mg per kg I.P. 
           F1 and F2 indicate analysis between samples and between animal sets respectively 
 Significance levels of F values: 
a
p<0.001; 
b
p<0.10 
≠≠ Two means not included in the same parenthesis are statistically significantly different at 
p<0.05.          
 
Figure 1: Relative percentage changes of C.pluricaulis activity on Strychnine (S) 
induced Convulsion. 
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‘1-5’ indicate C.pluricaulis in the 
doses of 100-500 mg/ kg bodyweight 
respectively, ‘6’ indicates Strychnine 
administered in the dose of 2 mg/ kg 
bodyweight , ‘7’ indicates Phenytoin 
sodium administered in the dose of  135 
mg/ kg bodyweight and ‘8’ indicates 
Phenytoin administered along with 
C.pluricaulis in the doses of 400 mg/ kg 
bodyweight. 
      From the observations it 
appeared that Convolvulus pluricaulis in 
the dosage of (100-500 mg/kg) has no 
significant inhibition effect on Strychnine 
induced convulsion, however Convolvulus 
pluricaulis in the dose of 400 mg/kg bw is 
administrated in combination with 
Phenytoin sodium (135 mg/kg bw) showed 
significant inhibitory effect on Strychnine 
induced convulsion. Thus the therapeutic 
index of Phenytoin sodium is enhanced by 
increasing LD50 value without altering 
ED50 value. 
 
Conclusion 
 It can be concluded that only the 
aqueous extract of Shankhapuspi 
(Convolvulus pluricaulis) (500 mg/kg bw) 
could not arrest seizure induced by 
Strychnine where as aqueous extract of 
Convolvulus pluricaulis in the dosage of 
400 mg/kg bw acted as co-therapeutic 
agent of Phenytoin sodium for arresting 
seizure induced by Strychnine Hcl (S). 
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